Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck

Cancer Treat Rep. 1987 Apr;71(4):425-6.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Clinical Trials as Topic
  • Drug Evaluation
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Ribavirin / adverse effects
  • Ribavirin / analogs & derivatives
  • Ribavirin / therapeutic use*
  • Ribonucleosides / therapeutic use*

Substances

  • Antineoplastic Agents
  • Ribonucleosides
  • Ribavirin
  • tiazofurin